Brief: Alkem Laboratories Q1 Consol Revenue From Operations 37.4 Billion Rupees
14/08/2026 09:17
BRIEF-Alkem Laboratories Q1 Consol Revenue From Operations 37.4 Billion Rupees Aug 14 (Reuters) - Alkem Laboratories Ltd ALKE.NS:
Q1 CONSOL NET PROFIT 5.2 BILLION RUPEES
Q1 CONSOL REVENUE FROM OPERATIONS 37.4 BILLION RUPEES
Source text: [ID:]
Further company coverage: ALKE.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Alkem Laboratories
See all newsBrief: Alkem Labs Approved Initiation Of Forensic Audit In Connection With Recent Incident Involving Alleged Misappropriation Of Funds By A Former Employee
Brief: Alkem Labs Launches Neuceno (Cenobamate) For Treatment Of Partial-Onset Seizures In Adult Patients
Brief: Alkem Labs Launches Renocia Exo, Ginsenoside Exosome-Based Hair Growth Serum
Brief: Alkem Labs Board Approves Investment Of Up To 750 Million Rupees For New Block At Baddi Manufacturing Facility
Brief: Alkem Laboratories Q1 Consol Revenue From Operations 37.4 Billion Rupees